Open Access
Original Research Article
Issue
J Oral Med Oral Surg
Volume 27, Number 4, 2021
Article Number 53
Number of page(s) 8
DOI https://doi.org/10.1051/mbcb/2021022
Published online 28 October 2021
  1. Kumar A. Haemangioma: a review of the literature and an unusual case report. EMJ 2017;2:31–35. [Google Scholar]
  2. Rohini T, Arularasan SG, Murugan M. Hemangiomas of head and neck − a review. IOSR J Dent Med Sci 2017;16:103–106. [Google Scholar]
  3. Dong JY, Ning JX, Li K, Liu C, Wang XX, Li RH, et al. Analysis of factors affecting the therapeutic effect of propranolol for infantile haemangioma of the head and neck. Sci Rep 2017;7:1–5. [Google Scholar]
  4. Ritter MR, Butschek RA, Friedlander M, Friedlander SF. Pathogenesis of infantile haemangioma: new molecular and cellular insights. Expert Rev Mol Med 2007;9:1–19. [Google Scholar]
  5. Luu M, Frieden IJ. Haemangioma: clinical course, complications and management. Br J Dermatol 2013;169:20–30. [Google Scholar]
  6. Richter GT, Friedman AB. Hemangiomas and vascular malformations: current theory and management. Int J Pediatr 2012;2012:1–10. [Google Scholar]
  7. Lo K, Mihm M, Fay A. Current theories on the pathogenesis of infantile hemangioma. Semin Ophthalmol 2009;24:172–177. [Google Scholar]
  8. Waner M, Buckmiller L, Suen JY. Surgical management of hemangiomas of the head and neck. Oper Tech Otolaryngol − Head Neck Surg 2002;13:77–84. [Google Scholar]
  9. Pienaar C, Graham R, Geldenhuys S, Hudson DA. Intralesional bleomycin for the treatment of hemangiomas. Plast Reconstr Surg 2006;117:221–226. [Google Scholar]
  10. Luo Q, Zhao F. How to use bleomycin A5 for infantile maxillofacial haemangiomas: clinical evaluation of 82 consecutive cases. J Cranio-Maxillofacial Surg 2011;39:482–486. [Google Scholar]
  11. Memon Y, Malik N, Anjum N, Ahmed SK, Saeed S. Ultrasound-guided Intralesional Bleomycin Injection (IBI) for treatment of cutaneous hemangiomas and vascular malformations. J Glob Radiol 2016;2: Article 2. [Google Scholar]
  12. Horbach SER, Rigter IM, Smitt JHS, Reekers JA, Spuls PI, Van Der Horst CMAM. Intralesional bleomycin injections for vascular malformations: a systematic review and meta-analysis. Plast Reconstr Surg 2016;137:244–256. [Google Scholar]
  13. Méndez-Echevarría A, Fernandez-Prieto A, De La Serna O, Lopez-Gutierrez JC, Parron M, Marin-Aguilera B, et al. Acute lung toxicity after intralesional bleomycin sclerotherapy. Pediatrics 2018;141. [Google Scholar]
  14. Gatea HK, Hassan MA, Abboud NJ. The role of intralesional bleomycin in the management of cutaneous infantile hemangioma. Iraqi Postgrad Med J 2018;17:204–211. [Google Scholar]
  15. Phung TL, Hochman M, Mihm MC. Current knowledge of the pathogenesis of infantile hemangiomas. Arch Facial Plast Surg 2005;7:319–321. [Google Scholar]
  16. Dickison P, Christou E, Wargon O. A prospective study of infantile hemangiomas with a focus on incidence and risk factors. Pediatr Dermatol 2011;28:663–669. [Google Scholar]
  17. Tiwary SK, Gupta RK, Kumar P, Khanna AK. Study of intralesional bleomycin sclerotherapy in hemangiomas. J Med Sci Clin Res 2019;7:399–405. [Google Scholar]
  18. Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, et al. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 2007;150:291–294. [Google Scholar]
  19. Greene AK. Management of hemangiomas and other vascular tumors. Clin Plast Surg 2011;38:45–63. [Google Scholar]
  20. Syed W, Bashir SA, Rasool A, Zaroo MI, Mohsin M, Zargar HR, et al. Intralesional bleomycin sclerotherapy for haemangiomas: prospective clinical study from Kashmir Valley. JK Pract 2016;21:17–24. [Google Scholar]
  21. Omidvari S, Nezakatgoo N, Ahmadloo N, Mosalaei A. Role of intralesional bleomycin in the treatment of complicated hemangiomas: prospective clinical study. Dermatol Surg 2005;31:499–501. [Google Scholar]
  22. Helal AA, Daboos MA. Five years' experience of combined intralesional therapy in infantile hemangioma. Ann Pediatr Surg 2019;15:4–9. [Google Scholar]
  23. Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet 2017;390:85–94. [Google Scholar]
  24. Waner M, North PE, Scherer KA, Frieden IJ, Waner A, Mihm MC. The nonrandom distribution of facial hemangiomas. Arch Dermatol 2003;139:869–75. [Google Scholar]
  25. Ethunandan M, Mellor TK. Haemangiomas and vascular malformations of the maxillofacial region—a review. Br J Oral Maxillofac Surg 2006;44:263–272. [Google Scholar]
  26. Kutluhan A, Bozdemir K, Ugras S. The treatment of tongue haemangioma by plasma knife surgery. Singapore Med J 2008;49:312–314. [Google Scholar]
  27. Düzenli Kar Y, Özdemir ZC, Acu B, Bör Ö. Infantile hemangioma: efficacy of low-dose propranolol and of intralesional bleomycin injection for propranolol non-response. Pediatr Int 2019;61:459–464. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.